BUZZ-Moderna rises after report on potential deal talks
I'm PortAI, I can summarize articles.
Shares of Modernarose 11.7% to $27.56 following reports of potential deal talks with a large drugmaker. The nature of the deal remains unclear, with possibilities of a buyout or partnership. Despite the rise, Moderna's shares have fallen over 90% from pandemic highs due to declining COVID revenue and political concerns. The company is focusing on R&D, aiming to bring three products to approval in 2025 and expanding its oncology portfolio. Year-to-date, the stock is down approximately 37%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments